A NEW FRONTIER IN INTRANASAL DRUG DELIVERY A clinical-stage pharmaceutical company leveraging its proprietary powder-based intranasal technology to develop innovative intranasal products Company Presentation – February 2026 Ticker NSRX Exchange NYSE American Please migrate color palette to match website Forward Looking Statements; Disclaimer This presentation of Nasus Pharma Ltd. (the "Company", "Nasus" or "Nasus Pharma") contains "forward-looking statements" within the meaning of the Private Securities Lit ...